Canadian Treat-and-Extend Analysis Trial With Ranibizumab in Patients With Neovascular AMD: CANTREAT Study 1-Year Results

Related

• 

  Founders' Award, Playing Your Part in Drug Development, Wiley Chambers, MD

  Wiley Chambers, MD

  Annual Meeting Talks

  2018

• 

  Surgical Case Conference

  Carl C. Awh, MD, FASRS

  Carl D. Regillo, MD

  Mohamed AlBahiti, MBBS, FRCSC

  Mohsin H. Ali, MD

  Nishikant J Borse, MS, FMRF, FASRS

  Jonathan S Chang, MD

  Albert Li, MD, FASRS

  Zofia Anna Nawrocka (vel Michalewska), MD, PhD

  Manish Nagpal, MD, FRCS (UK) ,FASRS

  Berna Ozkan, MD

  Uriel Rubin, MD

  Jayanth Sridhar, MD

  Victor M Villegas, MD

  Christina Y Weng, MD, MBA, FASRS

  Annual Meeting Talks

  2018

• 

  Differences in Metamorphopsia and OCT Changes After Retinal Detachment Repair: RCT Comparing Pneumatic Retinopexy to Vitrectomy at 1 Year (PIVOT Trial)

  Rajeev H. Muni, MD, MSC, FRCS(C), FASRS

  Annual Meeting Talks

  2018